Showing results (201-210 of 571) with videos related to
Sort By:
Pageof 58
Expert Opinion on Drug Metabolism & Toxicology|October 16, 2024
Switching from cangrelor to oral P2Y12 inhibitors: a focused review on drug-drug interactionsGiovanni Occhipinti, Luis Ortega-Paz, Francesco Franchi, et al.Thrombosis and Haemostasis|October 21, 2011
Platelet function profiles in the elderly: results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivityPiera Capranzano, Claudia Tamburino, Davide Capodanno, et al.Atherosclerosis|December 15, 2025
Association between C-reactive protein and adverse events in secondary cardiovascular prevention: A systematic review and meta-analysis of prognostic factor studiesRaffaele Piccolo, Angelo Laino, Antonio Pio Vitale, et al.Mayo Clinic Proceedings|February 5, 2025
Relevance of High Bleeding Risk and Postdischarge Bleeding in Patients Undergoing Percutaneous Coronary InterventionBrenden S Ingraham, Marco Valgimigli, Dominick J Angiolillo, et al.Journal of Interventional Cardiology|February 12, 2011
Does occlusion duration influence procedural and clinical outcome of patients who underwent percutaneous coronary intervention for chronic total occlusion?Salvatore D Tomasello, Luca Costanzo, Maria B Campisano, et al.Lancet (London, England)|April 18, 2021
Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysisMattia Galli, Stefano Benenati, Davide Capodanno, et al.JMIR Research Protocols|September 29, 2025
Vascular and Cardiovascular Outcomes of Smoking Cessation and Switching to Electronic Cigarette Use: Protocol for a Systematic Review of Prospective StudiesGiusy Rita Maria La Rosa, Jacqueline Yu, Giulio Geraci, et al.Journal of Clinical Medicine|August 14, 2025
Antiplatelet Monotherapies for Long-Term Secondary Prevention Following Percutaneous Coronary InterventionClaudio Laudani, Daniele Giacoppo, Antonio Greco, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 16, 2009
ClearWayRX system to reduce intracoronary thrombus in patients with acute coronary syndromes according to optical coherence tomography after abciximab intracoronary local infusion trial (COCTAIL): study rationale and designDavide Capodanno, Francesco Prati, Tomasz Pawlowsky, et al.International Journal of Cardiology|October 20, 2024
Downstream cangrelor versus upstream ticagrelor in patients with ST-segment elevation myocardial infarction: A propensity score-matched analysisAntonio Greco, Lorenzo Scalia, Claudio Laudani, et al.Pageof 58